Parkinson’s Disease is a disorder of the brain that leads to shaking, tremors, and difficulty with walking, movement, and coordination. This chronic progressive neurological disease affects nerve cells (neurons) in the substantia nigra area of the brain. When these cells are healthy, they produce dopamine, a neurotransmitting chemical that transmits signals between areas of the brain and coordinates smooth and balanced muscle movement. Parkinson’s Disease causes these nerve cells to die, affecting body movement, primary motor skills (resulting in resting tremors, rigidity, postural instability, and bradykinesia), secondary motor skills (resulting in freezing, unwanted accelerations, micrographia, and masked expressions), and non-motor skills (resulting in loss of smell, sleep disorders, mood disorders, constipation, and orthostatic hypotension).
Recent advancements in stem cell research and stem cell therapy practices have proven effective in the treatment of Parkinson’s Disease.
Since the majority of complications in Parkinson’s patients are related to the failure of the dopamine neurons to do its job, stem cell therapy may be used to directly target these neurons. By delivering adult stem cells directly to the brain, they can differentiate into dopamine producing neurons, diminishing the symptoms of the disease. Stem cell therapy procedures may also help patients who have been unresponsive to typical autoimmune disease drug treatments.
After the stem cells are extracted and prepared for injection, they may be administered in one of three ways: directly into the vein via a full body IV, intraspinal injections, or via direct site injections.
To learn more about stem cell therapy for Parkinson’s Disease, or to schedule a consultation with Dr. Santos at the Regenerative Cell Institute’s of Las Vegas, Nevada, or Mason City, Iowa, please contact us.